ArticleBioinformation2026
Cardiovascular risk prevention awareness and practices in type 2 diabetes: Linking HbA1c and lipid levels.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular risk remains a leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM), yet awareness and preventive practices are often inadequate. Therefore, it is of interest to evaluate cardiovascular risk prevention awareness and practices among T2DM patients and examined their correlation with HbA1c and lipid profiles. Data on lifestyle practices, medication adherence and risk awareness were collected and analyzed alongside glycemic and lipid parameters. Higher awareness and better preventive practices were significantly associated with improved glycemic control and favorable lipid levels. Thus, we show the importance of targeted patient education to enhance cardiovascular risk prevention and optimize metabolic outcomes in T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.